Cargando…
Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
INTRODUCTION: Tranylcypromine (TCP), an irreversible monoamine oxidase inhibitor (MAOI), is recommended for difficult-to-treat depression. Besides the requirement of a low-tyramine diet, there are concerns about the safety of TCP treatment during anaesthesia and electroconvulsive therapy (ECT). For...
Autores principales: | Kavakbasi, E., Ciftci, G.M., Tonkul, M., Baune, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565103/ http://dx.doi.org/10.1192/j.eurpsy.2022.671 |
Ejemplares similares
-
Efficacy and safety of intermittent theta burst stimulation (iTBS) in treatment resistant depression
por: Kavakbasi, E., et al.
Publicado: (2022) -
Differences in cognitive side-effects and seizure parameters between thiopental and propofol narcosis in ECT
por: Kavakbasi, E., et al.
Publicado: (2021) -
Impact of invasive VNS on depression severity and the need of concomitant drug and neuromodulatory treatment dose
por: Kavakbasi, E., et al.
Publicado: (2022) -
Postictal suppression in electroconvulsive therapy (ECT) according to sex, age, diagnosis and treatment phase
por: Llorca-Bofí, V., et al.
Publicado: (2021) -
Electroconvulsive therapy (ECT) and schizophrenia
por: Masin, Rhys, et al.
Publicado: (2021)